Literature DB >> 10654328

Distal myopathy in nephropathic cystinosis.

U Vester1, M Schubert, G Offner, J Brodehl.   

Abstract

In long-standing nephropathic cystinosis complications are observed in various organs. Distal myopathy was first described in detail in 1994. The prevalence was calculated to be 24%. We studied seven patients with nephropathic cystinosis with neurophysiological techniques. Only two patients complained of a distal muscle weakness but all showed signs of myopathy on electromyography, which was more pronounced in the distal muscles. Motor and sensory nerve conduction parameters were within normal ranges. One patient with the juvenile form of nephropathic cystinosis also had myopathy. We conclude that distal myopathy can be detected in nephropathic cystinosis even in the absence of clinically overt muscle weakness. Cystine-depleting therapy with cysteamine is recommended for all patients with cystinosis, even after renal transplantation, and the effect on the myopathy should be studied.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654328     DOI: 10.1007/s004670050009

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Chitotriosidase as a Novel Biomarker for Therapeutic Monitoring of Nephropathic Cystinosis.

Authors:  Koenraad R P Veys; Mohamed A Elmonem; Maria Van Dyck; Mirian C Janssen; Elisabeth A M Cornelissen; Katharina Hohenfellner; Giusi Prencipe; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  J Am Soc Nephrol       Date:  2020-04-09       Impact factor: 10.121

2.  Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis.

Authors:  Stéphanie Cherqui; Caroline Sevin; Ghislaine Hamard; Vasiliki Kalatzis; Mireille Sich; Marie O Pequignot; Karïn Gogat; Marc Abitbol; Michel Broyer; Marie-Claire Gubler; Corinne Antignac
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

3.  Clinical and neurophysiological characterization of early neuromuscular involvement in children and adolescents with nephropathic cystinosis.

Authors:  Nour Elkhateeb; Rasha Selim; Neveen A Soliman; Fatma M Atia; Ihab Ibrahim Abouelwoun; Mohamed A Elmonem; Rasha Helmy
Journal:  Pediatr Nephrol       Date:  2021-11-18       Impact factor: 3.651

4.  Management dilemmas in pediatric nephrology: Cystinosis.

Authors:  Martine T P Besouw; Maria Van Dyck; David Cassiman; Kathleen J Claes; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

Review 5.  Adult complications of nephropathic cystinosis: a systematic review.

Authors:  Rachel Nora Kasimer; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

Review 6.  Cystinosis: a review.

Authors:  Mohamed A Elmonem; Koenraad R Veys; Neveen A Soliman; Maria van Dyck; Lambertus P van den Heuvel; Elena Levtchenko
Journal:  Orphanet J Rare Dis       Date:  2016-04-22       Impact factor: 4.123

Review 7.  Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts.

Authors:  Dieter Haffner; Maren Leifheit-Nestler; Candide Alioli; Justine Bacchetta
Journal:  Cells       Date:  2022-01-05       Impact factor: 6.600

8.  Long-term tracking of neurological complications of encephalopathy and myopathy in a patient with nephropathic cystinosis: a case report and review of the literature.

Authors:  Marcus Müller; Andrea Baumeier; E B Ringelstein; I W Husstedt
Journal:  J Med Case Rep       Date:  2008-07-18

9.  Cystinosis beyond kidneys: gastrointestinal system and muscle involvement.

Authors:  Rezan Topaloglu; Ayşe Gültekingil; Bora Gülhan; Fatih Ozaltin; Hülya Demir; Türkmen Çiftci; Numan Demir; Çağrı Mesut Temucin; Aysel Yuce; Okhan Akhan
Journal:  BMC Gastroenterol       Date:  2020-07-29       Impact factor: 2.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.